Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

203
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

362
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
362
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

847
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
847
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

313
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
313
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

572
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
572

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Analysis of Patient Recovery and Opinions on Driving Post-Transcatheter Aortic Valve Insertion (TAVI): the TAVI-D Study.

CJC open·2026
Same author

Health economic simulation modeling of an AI-enabled clinical decision support system for coronary revascularization.

NPJ digital medicine·2026
Same author

Review of Transcatheter Aortic Valve Insertion (TAVI) Clinician Opinions on the Canadian Cardiovascular Society Post-TAVI Driving Guidelines.

CJC open·2025
Same author

Gamification in cardiothoracic surgical education: Time to learn more.

The Journal of thoracic and cardiovascular surgery·2024
Same author

A National Strategy to Detect and Treat Heart Valve Diseases in Canada.

The Canadian journal of cardiology·2023
Same author

Effects of Transcatheter Aortic Valve Implantation on Frailty and Quality of Life.

CJC open·2020

Related Experiment Video

Updated: Jan 8, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Comprehensive Machine Learning-Enabled Outcome Prediction for Patients With Coronary Artery Disease Using Multicentre

Emma Bogner1, Bryan Har2, Bing Li3

  • 1Data Intelligence for Health Lab, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

The Canadian Journal of Cardiology
|December 20, 2025
PubMed
Summary
This summary is machine-generated.

Machine learning models predict outcomes for coronary artery disease (CAD) patients using extensive data and external validation. These models offer robust, personalized prognosis to aid treatment decisions.

Keywords:
Machine learningclinical decision supportcoronary artery diseasecoronary revascularizationpatient outcome predictionpredictive modelling

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.7K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K

Related Experiment Videos

Last Updated: Jan 8, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.7K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K

Area of Science:

  • Cardiology
  • Artificial Intelligence
  • Health Informatics

Background:

  • Accurate prediction of patient outcomes is crucial for treatment decisions in coronary artery disease (CAD).
  • Previous machine learning (ML) models for CAD prediction were limited by small cohorts, restricted features, and internal validation.
  • This study aimed to develop and externally validate ML models using large-scale, multi-center data for obstructive CAD patients.

Purpose of the Study:

  • To develop and externally validate machine learning models for predicting short- and long-term outcomes in patients with obstructive coronary artery disease (CAD).
  • To assess the performance of traditional ML models and a transformer-based tabular foundation model (TabPFN).
  • To evaluate the feasibility of using limited pre-angiography data for real-time prediction.

Main Methods:

  • Utilized a large dataset of over 12,000 features from patients undergoing coronary angiography (2009-2019) across three Alberta hospitals.
  • Employed an extensive machine learning framework, including traditional models and the TabPFN model, to predict all-cause mortality and major adverse cardiovascular events (MACE) at multiple time points (90 days to 5 years).
  • Conducted secondary analyses using reduced feature sets of commonly available pre-angiography data to assess real-time prediction feasibility.

Main Results:

  • Included data from 44,462 catheterizations (38,767 patients).
  • External validation showed median areas under the receiver operating characteristic curves (AUC) for best models (primarily TabPFNs) ranging from 0.796-0.845 for mortality and 0.694-0.755 for MACE.
  • A minimal pre-angiography feature set achieved slightly reduced but still reasonable predictive performance.

Conclusions:

  • Large sample size, extensive features, external validation, and transformer architecture yielded personalized models with robust prediction performance.
  • The developed models demonstrate potential for improving treatment decision-making in CAD through accurate prognosis.
  • External validation confirms the generalizability and reliability of the predictive models for obstructive CAD patients.